1. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome 
M. Angeles Martínez-Zamora, M.B., Montserrat Creus, M.D., Dolors Tassies, M.D., Albert Bové, M.D., Juan Carlos Reverter, M.D., Francisco Carmona, M.D., Juan Balasch, M.D. 
Fertility and Sterility 
Volume 94, Issue 6, Pages (November 2010)
DOI: /j.fertnstert
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Box plot showing thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels determined by an enzyme-linked immunosorbent assay (ELISA) technique and clot lysis time (CLT) in antiphospholipid syndrome patients with ≥3 recurrent miscarriages (APS group), patients with ≥3 unexplained recurrent miscarriages (uRM group), and fertile controls (group C). Each box represents the middle 50% of the data (25% to 75% range). The central horizontal line represents the median. Vertical lines represent the 10% to 90% range of data, as indicated by the small horizontal lines. Statistical differences between groups are indicated.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions